title: Comment on: "One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients" by Boschetti et al.
authors.affiliation: Department of Clinical and Experimental Medicine, Endocrinology Unit, University of Messina, AOU Policlinico "G. Martino" (Block H, floor 4), Via Consolare Valeria, 1, Messina, 98125, Italy. curto.loren@libero.it.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Curtò
authors.affiliation: Department of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.
authors.forename: Cesare
authors.initials: C
authors.lastname: de Gregorio
mesh_terms: D000328:Adult; D013006:Growth Hormone; D006321:Heart; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone; D006801:Humans; D007334:Insulin-Like Growth Factor I
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone